09.04.2015 Views

ABSTRACTS from 16th International COnference on ... - CRRT Online

ABSTRACTS from 16th International COnference on ... - CRRT Online

ABSTRACTS from 16th International COnference on ... - CRRT Online

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<str<strong>on</strong>g>ABSTRACTS</str<strong>on</strong>g> FROM 17 TH INTERNATIONAL CONFERENCE ON <strong>CRRT</strong>,<br />

SAN DIEGO, FEB 14-17, 2012<br />

Fr diameter. Anticoagulati<strong>on</strong> was<br />

achieved with heparin. CVVHDF<br />

durati<strong>on</strong>s were 8, 3, 6, 2 and 5 days. No<br />

hemodynamic or technical issue<br />

occurred during the CVVHDF courses.<br />

Normalizati<strong>on</strong> of electrolyte balance was<br />

reached within the first 24 hours of<br />

CVVHDF. Four children received red<br />

cells transfusi<strong>on</strong> and 1 received platelets<br />

transfusi<strong>on</strong>. Patients were discharged<br />

after 1, 4, 7, 5, 7 days in PICU. One<br />

patient was readmitted for plasma<br />

exchange therapy. One patient had 4<br />

courses of intermittent hemodialysis<br />

after PICU discharge. C<strong>on</strong>clusi<strong>on</strong>:<br />

Recent technological progress has made<br />

CVVHDF safer and more reliable in<br />

young children. It allows a tighter<br />

c<strong>on</strong>trol of fluid and electrolyte balances<br />

in the first hours of treatment without<br />

hemodynamic impairment. Vascular<br />

access can be used for intermittent<br />

dialysis and/or plasma exchange therapy.<br />

Even in the absence of c<strong>on</strong>tra indicati<strong>on</strong><br />

for PD, first intenti<strong>on</strong> CVVHDF for<br />

young children with HUS is feasible and<br />

showed no major safety issue in this<br />

small case series.<br />

67. Post Filter I<strong>on</strong>ized Calcium Levels<br />

With Dilute Regi<strong>on</strong>al Citrate<br />

Anticoagulati<strong>on</strong>: Do We Need To<br />

Follow Them?<br />

Rajesh Speer, Dmitri Sychev, Ashita<br />

Tolwani<br />

University of Alabama at Birmingham<br />

Background: Although regi<strong>on</strong>al citrate<br />

anticoagulati<strong>on</strong> (RCA) with c<strong>on</strong>tinuous<br />

venovenous hemodiafiltrati<strong>on</strong><br />

(CVVHDF) has been shown to be safe<br />

and effective, it requires intensive<br />

m<strong>on</strong>itoring of i<strong>on</strong>ized calcium (iCa)<br />

levels every 6 hours <str<strong>on</strong>g>from</str<strong>on</strong>g> the patient as<br />

well as the circuit. At the University of<br />

Alabama at Birmingham (UAB),<br />

CVVHDF is performed with a .5%<br />

dilute citrate soluti<strong>on</strong> that serves as both<br />

an anticoagulant and replacement fluid<br />

(RF). Post filter iCa levels are checked<br />

every 6 hours and citrate adjusted to<br />

maintain a post filter iCa level of < .5<br />

mmol/L. The purpose of this study was<br />

to determine if measuring post filter iCa<br />

levels every 6 hours are necessary with<br />

the typical citrate RF and blood flow rate<br />

ranges used at UAB. Methods: This is a<br />

prospective analysis of post filter iCa<br />

levels in 1 critically ill patients using<br />

pre-diluti<strong>on</strong> CVVHDF. Post filter iCa<br />

levels were checked at varying<br />

combinati<strong>on</strong>s of citrate RF ranges of 15<br />

to 25 ml/hr, dialysate ranges of 15 to 25<br />

ml/hr, and blood flow rate ranges of 15<br />

to 2 ml/min. Patient demographics,<br />

electrolytes, as well as dialysate<br />

parameters were reviewed. Results: Post<br />

filter iCa levels remained

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!